IMMUNOSENESCENCE

/ DISEASE & DISORDERS, SCIENCE / By
  1. immunosenescence of ageing
  2. immunosenescence
  3. Inflamm‐aging: an evolutionary perspective on immunosenescence
  4. immunosenescence: emerging challenges for an ageing population
  5. Mechanisms of immunosenescence
  6. Human immunosenescence: is it infectious?
  7. Is immunosenescence infectious?
  8. immunosenescence and infectious diseases
  9. An evolutionary perspective on the mechanisms of immunosenescence
  10. immunosenescence: a review
  11. Understanding immunosenescence to improve responses to vaccines
  12. HIV infection, inflammation, immunosenescence, and aging
  13. immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?
  14. immunosenescence and cancer
  15. Factors that may impact on immunosenescence: an appraisal
  16. Oxidative stress, inflamm-aging and immunosenescence
  17. immunosenescence and HIV
  18. Moderate exercise may attenuate some aspects of immunosenescence
  19. Age and immunity: what is “immunosenescence”?
  20. Potential role of immunosenescence in cancer development
  21. immunosenescence: what does it mean to health outcomes in older adults?
  22. immunosenescence and cancer
  23. Innate and adaptive immunosenescence
  24. immunosenescence and vaccine failure in the elderly
  25. Cytomegalovirus and human immunosenescence
  26. Immunoproteasomes and immunosenescence
  27. The role of immunosenescence in the development of age-related diseases
  28. immunosenescence and human vaccine immune responses
  29. New advances in CMV and immunosenescence
  30. CMV and immunosenescence: from basics to clinics
  31. Rheumatoid arthritis: a role for immunosenescence?
  32. Human innate immunosenescence: causes and consequences for immunity in old age
  33. immunosenescence and cancer
  34. immunosenescence: implications for response to infection and vaccination in older people
  35. The cellular and subcellular bases of immunosenescence
  36. The impact of immunosenescence on pulmonary disease
  37. immunosenescence: deficits in adaptive immunity in the elderly
  38. immunosenescence: influenza vaccination and the elderly
  39. Social reversal of immunosenescence in honey bee workers
  40. Hallmarks of human “immunosenescence”: adaptation or dysregulation?
  41. The role of immunosenescence in neurodegenerative diseases
  42. immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention
  43. immunosenescence and lymphomagenesis
  44. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection
  45. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space
  46. The human immunosenescence phenotype: does it exist?
  47. Ageing, immunosenescence and inflammageing in the dog and cat
  48. T-cell immunosenescence: lessons learned from mouse models of aging
  49. Chronic stress and immunosenescence: a review
  50. immunosenescence in aging: between immune cells depletion and cytokines up-regulation
  51. immunosenescence: role and measurement in influenza vaccine response among the elderly
  52. immunosenescence of human natural killer cells
  53. immunosenescence in wild animals: meta‐analysis and outlook
  54. The untwining of immunosenescence and aging
  55. Cytometric analysis of immunosenescence
  56. immunosenescence and novel vaccination strategies for the elderly
  57. Hallmark features of immunosenescence are absent in familial longevity
  58. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?
  59. Sepsis and immunosenescence in the elderly patient: a review
  60. Nutrition, diet and immunosenescence
  61. immunosenescence and germinal center reaction
  62. Zinc homeostasis and immunosenescence
  63. Is immunosenescence influenced by our lifetime “dose” of exercise?
  64. Zinc, aging, and immunosenescence: an overview
  65. Human T cell immunosenescence and inflammation in aging
  66. immunosenescence: ageing of the immune system
  67. Basic biology and clinical impact of immunosenescence
  68. Reversing age-associated immunosenescence via exercise
  69. Reversing T cell immunosenescence: why, who, and how
  70. immunosenescence: a product of the environment?
  71. immunosenescence, autoimmunity, and rheumatoid arthritis
  72. immunosenescence of polymorphonuclear neutrophils
  73. COPD as a Disease of immunosenescence
  74. Aging, persistent viral infections, and immunosenescence: can exercise” make space”?
  75. immunosenescence in vertebrates and invertebrates
  76. B Cell immunosenescence
  77. A systems biology approach to the effect of aging, immunosenescence and vaccine response
  78. immunosenescence and immunogenetics of human longevity
  79. HIV as a cause of immune activation and immunosenescence
  80. NK and NKT cell functions in immunosenescence
  81. immunosenescence: a systems-level overview of immune cell biology and strategies for improving vaccine responses
  82. immunosenescence: implications for vaccination programmes in adults
  83. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load
  84. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence
  85. Cytomegalovirus infection: a driving force in human T cell immunosenescence
  86. The role of the thymus in immunosenescence: lessons from the study of thymectomized individuals
  87. Complexity of anti‐immunosenescence strategies in humans
  88. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans
  89. Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV
  90. immunosenescence and vaccine failure in the elderly: strategies for improving response
  91. Mechanisms underlying T cell immunosenescence: aging and cytomegalovirus infection
  92. Mechanisms of immunosenescence-lessons from models of accelerated immune aging
  93. immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: does age really matter?
  94. immunosenescence, inflammation and Alzheimer’s disease
  95. immunosenescence and challenges of vaccination against influenza in the aging population
  96. Mucosal immunosenescence: new developments and vaccines to control infectious diseases
  97. Probiotics and immunosenescence: cheese as a carrier
  98. immunosenescence and aging in HIV
  99. immunosenescence exacerbates the COVID-19
  100. Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response
  101. immunosenescence and influenza vaccine efficacy
  102. immunosenescence and Cytomegalovirus: where do we stand after a decade?
  103. Impact of immunosenescence on transplant outcome
  104. Frailty, inflammation and immunosenescence
  105. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence
  106. Stress and immunosenescence: The role of telomerase
  107. Oxidative stress and immunosenescence: therapeutic effects of melatonin
  108. Human immunosenescence: does it have an infectious component?
  109. Human cytomegalovirus infection and T cell immunosenescence: a mini review
  110. immunosenescence of microglia and macrophages: impact on the ageing central nervous system
  111. Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity
  112. The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence
  113. immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease
  114. immunosenescence, aging, and systemic lupus erythematous
  115. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence
  116. immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
  117. Effects of physical exercise on markers of cellular immunosenescence: a systematic review
  118. The interplay between immunosenescence and age-related diseases
  119. Contributions of age-related thymic involution to immunosenescence and inflammaging
  120. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients
  121. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence
  122. Rheumatoid arthritis, immunosenescence and the hallmarks of aging
  123. immunosenescence of macrophages: reduced MHC class II gene expression
  124. Molecular and cellular basis of immunosenescence
  125. … infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination—an impact of immunosenescence
  126. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study
  127. Zinc, infections and immunosenescence
  128. Leptin induces immunosenescence in human B cells
  129. The impact of the microbiome on immunosenescence
  130. Mitochondria, immunosenescence and inflammaging: a role for mitokines?
  131. Reversing immunosenescence for prevention of COVID-19
  132. immunosenescence and pneumococcal disease: an imbalance in host–pathogen interactions
  133. Helminth infections and immunosenescence: The friend of my enemy
  134. Cell therapy strategies to combat immunosenescence
  135. immunosenescence and organ transplantation
  136. Handbook of immunosenescence
  137. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence
  138. The role of DNA methylation and hydroxymethylation in immunosenescence
  139. Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
  140. A decline in p38 MAPK signaling underlies immunosenescence in Caenorhabditis elegans
  141. immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age‐associated microenvironmental changes
  142. immunosenescence and cancer: a review
  143. immunosenescence of natural killer cells, inflammation, and Alzheimer’s disease
  144. Intracellular signalling pathways: targets to reverse immunosenescence
  145. An association between immunosenescence and CD4+ CD25+ regulatory T cells: a systematic review
  146. The impact of senescence-associated T cells on immunosenescence and age-related disorders
  147. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults
  148. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review
  149. immunosenescence is both functional/adaptive and dysfunctional/maladaptive
  150. immunosenescence patterns differ between populations but not between sexes in a long-lived mammal
  151. Sex, gender and immunosenescence: a key to understand the different lifespan between men and women?
  152. immunosenescence in some but not all immune components in a free-living vertebrate, the tree swallow
  153. Cell-mediated immunosenescence in birds
  154. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence
  155. Preventing or reversing immunosenescence: can exercise be an immunotherapy?
  156. Cellular senescence, immunosenescence and HIV
  157. Immunological pathogenesis of main age-related diseases and frailty: role of immunosenescence
  158. Mucosal immunosenescence in the gastrointestinal tract: a mini-review
  159. Down syndrome, accelerated aging and immunosenescence
  160. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
  161. The role of pulmonary and systemic immunosenescence in acute lung injury
  162. CD4+ CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans—impact of immunosenescence
  163. immunosenescence comes of age: symposium on aging research in immunology: the impact of genomics
  164. The Interplay between immunosenescence and Microbiota in the Efficacy of Vaccines
  165. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence
  166. immunosenescence and vaccination in nursing home residents
  167. Is human immunosenescence clinically relevant? Looking for ‘immunological risk phenotypes’
  168. A model of premature aging in mice based on altered stress-related behavioral response and immunosenescence
  169. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza …
  170. Features of immunosenescence in women newly diagnosed with breast cancer
  171. Leukocyte function and life span in a murine model of premature immunosenescence
  172. immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart
  173. B cell immunosenescence: different features of naive and memory B cells in elderly
  174. Inflammation and neutrophil immunosenescence in health and disease: Targeted treatments to improve clinical outcomes in the elderly
  175. immunosenescence in HIV pathogenesis
  176. A Perspective on Roles Played by immunosenescence in the Pathobiology of Alzheimer’s Disease
  177. immunosenescence-related transcriptomic and immunologic changes in older individuals following influenza vaccination
  178. immunosenescence‐associated microRNAs in age and heart failure
  179. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence
  180. T cell immunosenescence after early life adversity: association with cytomegalovirus infection
  181. immunosenescence: the role of aging in the predisposition to neuro-infectious complications arising from the treatment of multiple sclerosis
  182. immunosenescence and immune response in organ transplantation
  183. T cell immunosenescence in vitro and in vivo
  184. immunosenescence.
  185. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint …
  186. Immune Cells and immunosenescence
  187. Caloric restriction and immunosenescence: a current perspective
  188. … of the potential implications of polyphenols in influencing the interrelationship between oxi-inflammatory stress, cellular senescence and immunosenescence during …
  189. Behavioral characterization of a mouse model of premature immunosenescence
  190. Psychoneuroendocrine interventions aimed at attenuating immunosenescence: a review
  191. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence
  192. A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence
  193. Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease
  194. Aging-associated immunosenescence via alterations in splenic immune cell populations in rat
  195. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects
  196. Unraveling the molecular mechanism of immunosenescence in Drosophila
  197. Peripheral immunosenescence and Central Neuroinflammation: A Dangerous Liaison-A Dietary Approach
  198. immunosenescence and age-related viral diseases
  199. Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice
  200. T-cell immunosenescence and inflammatory response in atomic bomb survivors
  201. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy
  202. immunosenescence is associated with presence of Kaposi’s sarcoma in antiretroviral treated HIV infection
  203. immunosenescence: limitations of natural killer cell-based cancer immunotherapy
  204. Successful immunosenescence and the remodelling of immune responses with ageing
  205. Age related changes in population of peripheral T cells: towards a model of immunosenescence
  206. Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression
  207. immunosenescence, suppression and tumour progression
  208. Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer
  209. immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?
  210. Apoptosis remodeling in immunosenescence: implications for strategies to delay ageing
  211. B cells and immunosenescence: a focus on IgG+ IgD− CD27−(DN) B cells in aged humans
  212. CD4+ T cells and immunosenescence–a mini-review
  213. 5th International Workshop on CMV and immunosenescence: a shadow of cytomegalovirus infection on immunological memory
  214. Consequences of immune system aging in nature: a study of immunosenescence costs in free‐living Tree Swallows
  215. Are skin senescence and immunosenescence linked within individuals?
  216. T-cell immunosenescence and its clinical relevance in man
  217. The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
  218. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and immunosenescence
  219. immunosenescence and resistance to parasite infection in the honey bee, Apis mellifera
  220. Senescent endothelial cells: potential modulators of immunosenescence and ageing
  221. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: a case report and review of literature
  222. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence
  223. Does regular exercise counter T cell immunosenescence reducing the risk of developing cancer and promoting successful treatment of malignancies?
  224. Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
  225. immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder
  226. Chronic antigenic load and apoptosis in immunosenescence
  227. Human T‐cell clones in long‐term culture as a model of immunosenescence
  228. immunosenescence of the equine immune system
  229. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition
  230. Impairment of gamma/delta T lymphocytes in elderly: implications for immunosenescence
  231. The emerging role of ECM crosslinking in T cell mobility as a hallmark of immunosenescence in humans
  232. immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
  233. CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence
  234. Factors associated with immunosenescence during early adulthood in HIV-infected patients after durable efficient combination antiretroviral therapy
  235. Sepsis and immunosenescence: closely associated in a vicious circle
  236. immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells
  237. Signs of innate immune activation and premature immunosenescence in psoriasis patients
  238. Molecular and cellular bases of immunosenescence, inflammation, and cardiovascular complications mimicking “inflammaging” in patients with systemic lupus …
  239. Report from the second cytomegalovirus and immunosenescence workshop
  240. immunosenescence and juvenile idiopathic arthritis
  241. Senescence-accelerated mice (SAMs) as a model for brain aging and immunosenescence
  242. Aging and systemic lupus erythematosus-immunosenescence and beyond
  243. Inflammation, immune activation, immunosenescence, and hormonal biomarkers in the frailty-related phenotype of men with or at risk for HIV infection
  244. Obesity as a model of premature immunosenescence
  245. Associations between chronic caregiving stress and T cell markers implicated in immunosenescence
  246. Zinc, metallothioneins and immunosenescence
  247. immunosenescence study of T cells: a systematic review
  248. Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients
  249. Should we Try to Alleviate immunosenescence and Inflammaging-Why, How and to What Extent?
  250. Aging, immunosenescence and membrane rafts: the lipid connection
  251. Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection
  252. Micronutrients that Affect immunosenescence
  253. immunosenescence in the nursing home elderly
  254. Specific patterns of CD4‐associated immunosenescence in vertically HIV‐infected subjects
  255. Neuroendocrine and viral correlates of premature immunosenescence
  256. immunosenescence and gender: a study in healthy Cubans
  257. immunosenescence is associated with altered gene expression and epigenetic regulation in primary and secondary immune organs
  258. immunosenescence: participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes
  259. From immunosenescence to immune modulation’: a re-appraisal of the role of cytomegalovirus as major regulator of human immune function
  260. Premature immunosenescence is associated with memory dysfunction in rheumatoid arthritis
  261. Lifelong exercise practice and immunosenescence: Master athletes cytokine response to acute exercise
  262. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
  263. Pharmacological advantages of melatonin in immunosenescence by improving activity of T lymphocytes
  264. Down syndrome: is it really characterized by precocious immunosenescence?
  265. Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
  266. Impaired immune response in old mice suffering from obesity and premature immunosenescence in adulthood
  267. Endoplasmic reticulum stress caused by lipoprotein accumulation suppresses immunity against bacterial pathogens and contributes to immunosenescence
  268. immunosenescence: the importance of considering age in health and disease
  269. Circulating T-cell immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based …
  270. Seasonal trade–offs in cell–mediated immunosenescence in ruffs (Philomachus pugnax)
  271. Robustness and fragility in immunosenescence
  272. Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome
  273. Targeting Inflammation and immunosenescence to improve vaccine responses in the elderly
  274. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?
  275. Hallmarks of Aging and immunosenescence: Connecting the Dots
  276. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial
  277. Aging and immunosenescence in invertebrates
  278. immunosenescence and its influence on reproduction in a long-lived vertebrate
  279. immunosenescence and cancer vaccines
  280. Decreasing pro-inflammatory cytokine and reversing the immunosenescence with extracts of Pu-erh tea in senescence accelerated mouse (SAM)
  281. Loss of CD127 & increased immunosenescence of T cell subsets in HIV infected individuals
  282. Do natural antibodies compensate for humoral immunosenescence in tropical pythons?
  283. Reactive oxygen intermediate-induced pathomechanisms contribute to immunosenescence, chronic inflammation and autoimmunity
  284. Accelerated immunosenescence in preindustrial twin mothers
  285. immunosenescence and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts.
  286. HIV infection-related premature immunosenescence: high rates of immune exhaustion after short time of infection
  287. Avian immunosenescence
  288. immunosenescence: potential causes and strategies for reversal
  289. The complex relationship between immunosenescence and Inflammaging: Special issue on the New Biomedical Perspectives
  290. immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity
  291. Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach
  292. CD8+ immunosenescence predicts post-transplant cutaneous squamous cell carcinoma in high-risk patients
  293. Association between immunosenescence phenotypes and pre-frailty in older subjects: does cytomegalovirus play a role?
  294. Circulating T-cell immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based …
  295. Role of redox imbalance in the molecular mechanisms responsible for immunosenescence
  296. The twilight of the immune system: The impact of immunosenescence in aging
  297. High perceived stress in women is linked to oxidation, inflammation and immunosenescence
  298. Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice
  299. Understanding immunosenescence and its impact on vaccination of older adults
  300. immunosenescence and vaccination
  301. The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old
  302. Cellular immunosenescence: an overview
  303. Common variable immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
  304. Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence
  305. T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence?
  306. Mitochondrial DNA damage in lymphocytes: a role in immunosenescence?
  307. Probiotics as anti-immunosenescence agents
  308. Beneficial and detrimental effects of antiretroviral therapy on HIV-associated immunosenescence
  309. Homocysteine induces DNA damage and alterations in proliferative capacity of T-lymphocytes: a model for immunosenescence?
  310. immunosenescence and the ability to survive bacterial infection in the red flour beetle Tribolium castaneum
  311. An inflammatory clock predicts multi-morbidity, immunosenescence and cardiovascular aging in humans
  312. The In Vitro Influence of a Genetic Superoxide-Hydrogen Peroxide Imbalance on immunosenescence
  313. The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental …
  314. immunosenescence: a key player in cancer development
  315. Tumor Microenvironment-Regulating immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity
  316. immunosenescence profiles are not associated with muscle strength, physical performance and sarcopenia risk in very old adults: The Newcastle 85+ Study
  317. Cellular immunosenescence in adult male crickets, Gryllus assimilis
  318. immunosenescence: clinical and pharmacologic considerations
  319. Regulation of autophagy as a therapy for immunosenescence‐driven cancer and neurodegenerative diseases: The role of exercise
  320. MicroRNAs (MiRs) precisely regulate immune system development and function in immunosenescence process
  321. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2-induced interferon gamma secretion
  322. Alzheimer’s disease, neuroprotection, and CNS immunosenescence
  323. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients
  324. Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study
  325. Effects of fish oil on HIV-related inflammation and markers of immunosenescence: a randomized clinical trial
  326. immunosenescence and age-related susceptibility to influenza virus in Japanese quail
  327. immunosenescence and vaccination of the elderly I. Age-related immune impairment
  328. Cellular basis of immunosenescence
  329. Update of immunosenescence in Cerebral Small Vessel Disease
  330. immunosenescence phenotypes in the telomerase knockout mouse
  331. Cellular immunosenescence
  332. Do membrane rafts contribute to human immunosenescence?
  333. The innate immune system and aging: what is the contribution to immunosenescence?
  334. immunosenescence induced by plasma from individuals with obesity caused cell signaling dysfunction and inflammation
  335. An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics
  336. Age-related immunosenescence in Fischer 344 rats: influence of exercise training
  337. Systematic expression profiling of innate immune genes defines a complex pattern of immunosenescence in peripheral and intestinal leukocytes
  338. Modulation of canine immunosenescence by life-long caloric restriction
  339. Emergence of T cell immunosenescence in diabetic chronic kidney disease
  340. Intestinal mucosal immunosenescence in rats
  341. Ovariectomy causes immunosenescence and oxi-inflamm-ageing in peritoneal leukocytes of aged female mice similar to that in aged males
  342. Cytomegalovirus driven immunosenescence—An immune phenotype with or without clinical impact?
  343. Chronic alcohol increases CD8+ T-cell immunosenescence in simian immunodeficiency virus-infected rhesus macaques
  344. Growing old with the immune system: a study of immunosenescence in the zebra finch (Taeniopygia guttata)
  345. immunosenescence and Cancer Immunotherapy at Old Age: Basics
  346. Immunomodulatory role of high-density lipoproteins: impact on immunosenescence
  347. Role of hormones in the regulation of RACK1 expression as a signaling checkpoint in immunosenescence
  348. … Interleukin-6 (IL-6), and DHEA Inhibits IL-6 Secretion from Mononuclear Cells in Man in Vitro: Possible Link between Endocrinosenescence and immunosenescence
  349. Characterization of intrinsic and extrinsic risk factors for celery allergy in immunosenescence
  350. Insights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model
  351. Effect of polysaccharides from a Korean ginseng berry on the immunosenescence of aged mice
  352. Heterogeneity in thymic emigrants: implications for thymectomy and immunosenescence
  353. Extracts of Cistanche deserticola can antagonize immunosenescence and extend life span in senescence-accelerated mouse prone 8 (SAM-P8) mice
  354. immunosenescence in persons with spinal cord injury in relation to urinary tract infections-a cross-sectional study
  355. Zinc, oxidative stress, genetic background and immunosenescence: implications for healthy ageing
  356. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence
  357. Horticultural Therapy Reduces Biomarkers of immunosenescence and Inflammaging in Community-Dwelling Older Adults: A Feasibility Pilot Randomized Controlled …
  358. Fasting, dietary restriction, and immunosenescence
  359. Hallmarks of aging and immunosenescence: Connecting the dots.
  360. … 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence
  361. immunosenescence: implications for vaccination programs in the elderly
  362. New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, and immunosenescence
  363. Oxidative stress and immunosenescence in spleen of obese mice can be reversed by 2‐hydroxyoleic acid
  364. immunosenescence in testicular cancer survivors: potential implications of cancer therapies and psychological distress
  365. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis
  366. Acupuncture for sleep quality, BDNF levels and immunosenescence: a randomized controlled study
  367. Is chronic exposure to low-dose organochlorine pesticides a new risk factor of T-cell immunosenescence?
  368. immunosenescence and immunotherapy in elderly acute myeloid leukemia patients: Time for a biology-driven approach
  369. Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery
  370. Gene expression changes in long‐term culture of T‐cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence
  371. Preferential accumulation of mature NK cells during human immunosenescence
  372. T cell markers recount the course of immunosenescence in healthy individuals and chronic kidney disease
  373. immunosenescence in honey bees (Apis mellifera L.) is caused by intrinsic senescence and behavioral physiology
  374. The Paradigm of immunosenescence in Atherosclerosis-Cardiovascular Disease (ASCVD)
  375. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19
  376. Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults
  377. A stochastic model for CD8+ T cell dynamics in human immunosenescence: implications for survival and longevity
  378. Compartmentalization of immunosenescence: a deeper look at the mucosa
  379. Decreased proportion of cytomegalovirus specific CD8 T-cells but no signs of general immunosenescence in Alzheimer’s disease
  380. Juxtaposition of system dynamics and agent-based simulation for a case study in immunosenescence
  381. Where Could Research on immunosenescence Lead?
  382. Erosive pustular dermatosis: a manifestation of immunosenescence a report of 8 cases
  383. Evidence for less marked potential signs of T-cell immunosenescence in centenarian offspring than in the general age-matched population
  384. The role of CMV in immunosenescence
  385. A role for SKN-1/Nrf in pathogen resistance and immunosenescence in Caenorhabditis elegans
  386. Lymphocyte modulation in a baboon model of immunosenescence
  387. Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis?
  388. Insect models of immunosenescence
  389. Why the elderly appear to be more severely affected by COVID‐19: the potential role of immunosenescence and CMV
  390. immunosenescence-like state is accelerated by constant light exposure and counteracted by melatonin or turmeric administration through DJ-1/Nrf2 and P53 …
  391. Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people.
  392. Detectable viral load aggravates immunosenescence features of CD8 T-cell subsets in vertically HIV-infected children
  393. immunosenescence in patients with chronic systolic heart failure
  394. Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation
  395. immunosenescence and human longevity
  396. Oxidative stress, inflammaging, and immunosenescence
  397. The role of gender and labour status in immunosenescence of 65+ Polish population
  398. Molecular and cell biological studies of ageing and their application to considerations of T lymphocyte immunosenescence
  399. immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells
  400. Interleukin-7 and immunosenescence
  401. Hormones, genetic program and immunosenescence.
  402. immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L) 1 inhibitors (IO …
  403. Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
  404. immunosenescence
  405. T‐cell Immunoglobulin and ITIM Domain Contributes to CD8+ T‐cell immunosenescence
  406. Zinc-binding proteins (metallothionein and α-2 macroglobulin) and immunosenescence
  407. Viruses and immunosenescence–more players in the game
  408. immunosenescence and Respiratory Infections Among Nursing Home Residents
  409. Nutritional regulation of immunosenescence for heart health
  410. Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection
  411. Aging immunity, immunosenescence, or inflamm-aging: a comparative study of cytokines
  412. Cell Proliferation and Cell Death in immunosenescence a
  413. A road to ruins: An insight into immunosenescence
  414. Acquired immunity: immunosenescence and physical activity
  415. immunosenescence in neurocritical care
  416. Review on immunosenescence
  417. immunosenescence profile and expression of the aging biomarker (p16 INK4a) in testicular cancer survivors treated with chemotherapy
  418. Protein kinase C alpha-mediated chronic signal transduction for immunosenescence.
  419. immunosenescence
  420. immunosenescence and vaccinations in the elderly
  421. immunosenescence and hurdles in the clinical management of older HIV-patients
  422. Premature immunosenescence in catecholamines syntesis deficient mice. Effect of social environment
  423. Are There Reliable Biomarkers for immunosenescence and Inflammaging?
  424. The pathogenesis of age-related macular degeneration is not inflammatory mediated but is instead due to immunosenescence-related failure of tissue repair
  425. Senile dementia, Alzheimer type: a distinct entity in the immunosenescence?
  426. immunosenescence in a captive semelparous marsupial, the red-tailed phascogale (Phascogale calura)
  427. immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment
  428. Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV …
  429. immunosenescence of the CD8+ T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue …
  430. A mathematical model for the immunosenescence.
  431. immunosenescence Revisited
  432. A review of chronic kidney disease and the immune system: a special form of immunosenescence
  433. Nutritional zinc, oxidative stress and immunosenescence: biochemical, genetic, and lifestyle implications for healthy ageing
  434. Nutrition as a Tool to Reverse immunosenescence?
  435. Telomere-based therapy for immunosenescence
  436. Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for activated C kinase 1: implications in immunosenescence
  437. immunosenescence AND INFLAMM-AGEING.
  438. A new paradigm about HERV-K102 particle production and blocked release to explain cortisol mediated immunosenescence and age-associated risk of …
  439. Telomere length measurement and determination of immunosenescence‐related markers (CD28, CD45RO, CD45RA, interferon‐γ and interleukin‐4) in skin‐homing …
  440. Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into …
  441. Socio-economic status and immunosenescence
  442. immunosenescence and CoQ10
  443. The effects of aging and maternal protein restriction during lactation on thymic involution and peripheral immunosenescence in adult mice
  444. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans
  445. T cell immunosenescence, hypertension, and arterial stiffness
  446. The immunosenescence.
  447. immunosenescence of human NK cells: effects on tumor target recognition, lethal hit and interferon sensitivity
  448. T cell immunosenescence
  449. immunosenescence: Mechanisms, Clinical Impacts, and Therapeutic Strategies
  450. HIV and aging as a model for immunosenescence
  451. Injection of T-cell receptor peptide reduces immunosenescence in aged C57BL/6 mice.
  452. Signal transduction mechanisms in the immune system: potential implication in immunosenescence
  453. immunosenescence, oxidative stress, and cancers
  454. immunosenescence and SARS-CoV-2 Vaccine Development
  455. Chronic antigenic stress, immunosenescence and human survivorship over the 3 last centuries: heuristic value of a mathematical model
  456. Noni (Morinda citrifolia L.) fruit juice delays immunosenescence in the lymphocytes in lymph nodes of old F344 rats
  457. Nonhuman Primate Models of immunosenescence
  458. immunosenescence and senescence immunosurveillance: one of the possible links explaining the cancer incidence in ageing population
  459. immunosenescence: immune deficits in the elderly and therapeutic strategies to enhance immune competence
  460. Role of some selected Bifidobacterium strains in modulating immunosenescence of aged albino rats
  461. Role of zinc and selenium in oxidative stress and immunosenescence: implications for healthy ageing and longevity
  462. Proceedings of a symposium on “immunosenescence—a major cause of disease in the elderly: from molecules to patients”: Summary
  463. immunosenescence does not abrogate engraftment of murine allogeneic bone marrow
  464. immunosenescence and its potential modulation: lessons from mouse models
  465. Immune system aging may be affected by HIV infection: the mathematical model of immunosenescence
  466. Flagellin‐dependent TLR 5/caveolin‐1 as a promising immune activator in immunosenescence
  467. Glucocorticoids and Dehydroepiandrosterone: A Role in immunosenescence?
  468. Castration reverses immunosenescence in aged mice
  469. Cellular immunosenescence in F344 rats: Decline in responsiveness to phytohemagglutini involves changes in both T cells and macrophages
  470. Skin immunosenescence: decreased receptor for activated C kinase‐1 expression correlates with defective tumour necrosis factor‐α production in epidermal cells
  471. TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients
  472. Kaposi’s sarcoma in a treated and well-controlled HIV infected patient: Discussion on the role of immunosenescence
  473. Aging, immunosenescence, and Cancer
  474. Premature immunosenescence: a pathogenetic factor in Alzheimer’s disease?
  475. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime
  476. Is Aging and immunosenescence a Risk Factor For Dimethyl Fumarate Induced PML?(P2. 088)
  477. immunosenescence, Inflammaging, and Their Implications for Cancer and Anemia
  478. Premature immunosenescence impairs immune surveillance allowing the endometriotic stem cell to migrate: The cytokine profile as a common denominator
  479. immunosenescence
  480. Sex hormones and immunosenescence
  481. Role of immunosenescence in infections and sepsis in the elderly
  482. immunosenescence-inevitable or preventable?: review articles
  483. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption-an observational …
  484. Spontaneous HIV controllers might be the key to prevent accelerated immunosenescence of effector CD8+ T cells
  485. … progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence
  486. Immune System, immunosenescence and Immunisation in the Elderly
  487. immunosenescence and the gut microbiota: the role of probiotics and prebiotics
  488. Nutraceuticals in immunosenescence
  489. The somatotrope growth hormone-releasing hormone/growth hormone/insulin-like growth factor-1 axis in immunoregulation and immunosenescence
  490. immunosenescence
  491. Chronic viral infections and immunosenescence, with a focus on CMV
  492. Somatotrope GHRH/GH/IGF-1 axis at the crossroad between immunosenescence and elder frailty
  493. Diet and immunosenescence
  494. Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells
  495. Handbook on immunosenescence: Basic Understanding and Clinical Applications
  496. Cellular immunosenescence in F344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon …
  497. immunosenescence-the role in the immunotherapy of older population.
  498. Cancer, Ageing and immunosenescence
  499. immunosenescence: implications for cancer immunotherapy in elderly patients
  500. HIV dynamics and immunosenescence
  501. Breast cancer and immunosenescence
  502. The influence of immunosenescence on tumor growth and spread: lessons from animal models.
  503. Melatonin and tryptophan as therapeutic agents against the impairment of the sleep-wake cycle and immunosenescence due to aging in Streptopelia risoria
  504. immunosenescence in Montecatini
  505. immunosenescence of the human B cell system: impaired activation/proliferation in response to autologous monocytes pulsed with Staph protein A and the effects of …
  506. immunosenescence and the ageing lung
  507. immunosenescence (iSenescence) correlates with progression (PD) to PD-(L) 1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell …
  508. … -MS ProteinChip array profiling of T-cell clones propagated in long-term culture identifies human profilin-1 as a potential bio-marker of immunosenescence
  509. Clinical and experimental study on retardation of immunosenescence by kidney tonifying principle
  510. Post-thymic CD4 positive cytotoxic T cell infiltrates of the skin: A clinical and histomorphologic spectrum of the unique CD4 positive T cell of immunosenescence
  511. Effects of Heavy Drinking on T‐Cell Phenotypes Consistent with immunosenescence in Untreated HIV Infection
  512. Current status and future prospects in the search for protein biomarkers of immunosenescence
  513. CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
  514. Markers of premature immunosenescence in the peripheral blood of multiple sclerosis subjects vs. healthy controls
  515. Impaired immunity and increased risk of infections in older adults: impact of chronic disease on immunosenescence
  516. Biological and chronological age in heart failure: role of immunosenescence
  517. immunosenescence and its role in cancer
  518. Coronavirus Disease (COVID-19): A Perspective from immunosenescence
  519. immunosenescence: ageing of the immune system
  520. immunosenescence in horses
  521. immunosenescence and late life depression
  522. Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine
  523. Investigation of D-galactose Induced Cellular and Organic immunosenescence [J]
  524. Neutrophil ageing and immunosenescence
  525. Modeling of immunosenescence and Risk of Death from Respiratory Infections: Evaluation of the Role of Antigenic Load and Population Heterogeneity
  526. A theoretical model for’in machina’: Experiments on immunosenescence
  527. Role of TLR polymorphisms in immunosenescence
  528. immunosenescence of CD4+ T cells in male homosexual patients with HIV-1 infection
  529. immunosenescence: What is It and What Can Be Done About It?
  530. Effect of immunosenescence on the induction of cardiovascular disease pathogenesis: role of peripheral blood mononuclear cells
  531. The role of stress and adrenal hormones in immunosenescence
  532. Perspectives: is immunosenescence clinically relevant?
  533. immunosenescence-related Markers of T Cell Subsets in Conventional Lymphocyte Immunophenotyping
  534. Mechanisms of immunosenescence Short report
  535. Exercise, Sarcopenia and immunosenescence
  536. T Cell-mediated immunity in the immunosenescence process
  537. HIV infection as a model of accelerated immunosenescence
  538. Lifestyle Exercise Attenuates immunosenescence; Flow Cytometry Analysis
  539. Cytokine polymorphisms and immunosenescence
  540. Insulin resistance, chronic inflammation and the link with immunosenescence
  541. Imaging immunosenescence
  542. Zinc, aging, and immunosenescence: an overview
  543. UNDERSTANDING AND ADDRESSING immunosenescence
  544. Basic biology and clinical impact of immunosenescence
  545. Inhibition of Fas‐mediated apoptotic cell death of murine T lymphocytes in a mouse model of immunosenescence in linkage to deterioration in cell membrane raft …
  546. Proteasome activity and immunosenescence
  547. immunosenescence of Lymphocytes T and Implications for Age-Related Disorders
  548. Mucosal Vaccines for Aged: Challenges and Struggles in immunosenescence
  549. immunosenescence in rheumatoid arthritis: Use of CD28 negative T cells to predict treatment response
  550. Effects of immunosenescence on the Lower Expression of Surface Molecules in Neutrophils and Lymphocytes
  551. Update of skin immunosenescence in geriatric population
  552. Glucocorticoids and DHEA: Do they have a role in immunosenescence?
  553. Antibody repertoire sequencing reveals systemic and mucosal immunosenescence in the short-lived turquoise killifish
  554. immunosenescence: analysis and genetic modulation of replicative senescence in T cells
  555. immunosenescence: A Study in Healthy Elderly Population
  556. immunosenescence modulation by vaccination
  557. Age-Independent immunosenescence: An Antigen-Activated, Sexually Dimorphic Program Predicts Inflammation of Aging and HIV-1 Susceptibility
  558. UNDERSTANDING AND ADDRESSING immunosenescence
  559. Cancer-associated im‐mune deficiency: A form of accelerated immunosenescence
  560. Mathematical modeling of immunosenescence: scenarios, processes and limitations
  561. The role of microRNAs in immunosenescence process
  562. immunosenescence and Cutaneous Malignancies
  563. immunosenescence and nutrition: reviewing clinical evidence on pre-, pro-and synbiotics in aging
  564. … healthspan and lifespan in mice by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis and immunosenescence
  565. Cultured T cell clones as models for immunosenescence
  566. Apoptosis and immunosenescence
  567. immunosenescence and Aging
  568. Centenarians overexpress BCL-xL, which confers them a protection against apoptosis, oxidative stress and immunosenescence
  569. Dendritic cells in immunosenescence
  570. Cellular Response to Stress: At the Crossroads between immunosenescence and Cancer
  571. Fructus Lycii influence investigation to thymus function in D-galactose induced immunosenescence mouse model [J]
  572. Study of T Cell immunosenescence in Various Tissue Compartments
  573. Premature immunosenescence in triple-transgenic mice for Alzheimer’s disease
  574. Growth differentiation factor-15 is associated with age-related monocyte immunosenescence
  575. Does chronic caregiving stress accelerate T cell immunosenescence?
  576. immunosenescence
  577. Immunological analysis of myeloid derived suppressor cell (MDSC): Osteoclast differentiation and immunosenescence
  578. Innate immunosenescence and its impact on health in old age
  579. Transgenic mouse models for immunosenescence
  580. immunosenescence.
  581. Correlation research on immunosenescence and cells of the innate immune system
  582. immunosenescence and the 3Rs: Restoration, Replacement and Reprogramming
  583. immunosenescence: More research is needed
  584. A Matter of Life and Death of T-Lymphocytes in immunosenescence
  585. Zinc-Binding Proteins and immunosenescence: Implications as Biological and Genetic Markers
  586. Exercise and immunosenescence
  587. immunosenescence, thymic involution and autoimmunity
  588. Obesity and immunosenescence: Psychological, Behavioral and Biochemical Pathways
  589. immunosenescence: The Forefront of Infection and Trophic Control
  590. immunosenescence and Physical Exercise Intervention: For the Prevention of Senile Disease
  591. The characteristic of immunity in long-lived persons and selection of the immunosenescence markers
  592. SENIEUR status of the originating cell donor negates certain ‘anti-immunosenescence‘effects of ebselen and N-acetyl cysteine in human T cell clone cultures
  593. immunosenescence-the sunset over the immune system.
  594. IL-7 concentration is increased in nonagenarians but is not associated with markers of T cell immunosenescence
  595. EVALUATION OF THE BASELINE CHARACTERISTICS AND immunosenescence OF BLOOD LYMPHOCYTES AMONG ELDERLY HIV-INFECTED PATIENTS IN …
  596. A discrete HIV infection model with immunosenescence
  597. Erratum to Zinc, infections and immunosenescence-(Mech. Ageing Develop. 121 (2000) 21-35)
  598. Understanding immunosenescence in Aging-Related Diseases With Quantitative Proteomics
  599. Signs of immunosenescence in patients diagnosed with non-small cell lung cancer
  600. immunosenescence and infectious diseases
  601. Strategies to overcome the age-old problem of immunosenescence
  602. İmmunosenescence and The İmportance of İnfluenza and Pneumococcal Vaccine in Elderly?
  603. immunosenescence and human NK cells
  604. Natural killer cell immunosenescence and cancer in the elderly
  605. Inflammation and neutrophil immunosenescence in health and disease
  606. The evolution of avian lifespan: an examination of telomere dynamics and immunosenescence
  607. Progressive immunosenescence in diabetic chronic kidney disease
  608. UNDERSTANDING immunosenescence, LIFE-SPAN IMMUNIZATION, AND NOVEL PREVENTIVE OPTIONS
  609. Precision Medicine: Focus on Age-independent immunosenescence
  610. Comparative Study on immunosenescence Modulation Effect of Tonifying Kidney Removing Blood Stasis and Tonifying Kidney Invigorating Spleen Removing Blood …
  611. Oxidative stress and immunosenescence
  612. A study of cytomegalovirus infection, cognitive ability and immunosenescence in older adults
  613. immunosenescence in Type 2 Diabetic Patients with Chronic Renal Disease
  614. immunosenescence: delayed cutaneous hypersensitivity tests in independently-living Chilean elderly individuals
  615. IMPACT OF OBSTRUCTIVE SLEEP APNOEA AND TREATMENT RESPONSE ON immunosenescence PARAMETERS IN HYPERTENSION
  616. Regulating effect and mechanism of electroacupuncture with shuanggu yitong prescription methods on immunosenescence in aging rats with yang deficiency
  617. Effects of aging on immunosenescence and checkpoint inhibitor efficacy in a C57BL/6J syngeneic model
  618. immunosenescence and Host-Pathogen Relationships: The example of Influenza
  619. Clinical relevance of immunosenescence
  620. ADJUVANTED VACCINES TO ADDRESS immunosenescence AND PROMOTE HEALTH THROUGHOUT LIFE
  621. Immune system changes and immunosenescence
  622. immunosenescence in HIV infection
  623. The Impact of Diet on immunosenescence
  624. immunosenescence and the importance of age in risk stratification of progressive multifocal leukoencephalopathy (P2. 318)
  625. immunosenescence and cancer immunotherapy.
  626. The ageing immune system: can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?
  627. immunosenescence under an evolutionary perspective
  628. Exaggerated neutrophil immunosenescence in sepsis and its potential modification with simvastatin
  629. New Advances in CMV and immunosenescence
  630. As time goes by… Would CD4+ T cells depletion induce early immunosenescence in HIV infected patients?
  631. Hyperactive cytokine T-cell response is associated with immunosenescence in severe acute COVID-19 infection
  632. Evidence for immunosenescence in natural populations.
  633. immunosenescence and gender: a study in healthy Cubans.
  634. HORMONES, GENETIC PROGRAM AND immunosenescence
  635. immunosenescence and Its Aplications to Artificial Immune Systems
  636. Resistance training and immunosenescence of the innate immune system
  637. Mouse Models and Genetics of immunosenescence
  638. Mitochondria and immunosenescence
  639. Effects of serums containing Buzhong Yiqi decoction with Astragalus Radix or Hedysari Radix on anti-immunosenescence in spleen lymphocytes of SAMP8 mice
  640. Challenges of vaccination in older people. Can we circumvent immunosenescence?
  641. immunosenescence and exercise-mediated modulation of the innate immune response to Influenza infection in mice
  642. T cell immunosenescence is associated with the presence of Kaposi’s sarcoma in antiretroviral treated human immunodeficiency virus-infected persons
  643. immunosenescence: the reason older adults are more vulnerable to viruses, and how to prevent it–Part
  644. A transgenic dwarf rat strain as a tool for the study of immunosenescence in aging rats and the effect of calorie restriction
  645. immunosenescence and vaccination in the elderly [J]
  646. Exercise Training and immunosenescence
  647. Correlational Research of immunosenescence and the Change of T, B Cell
  648. Markers of immunosenescence in the peripheral blood of multiple sclerosis subjects compared to healthy controls
  649. AGING TREATMENT BY COUNTERACTING INTRINSIC DNA DAMAGE AND immunosenescence
  650. Characterization of human plasma extracellular vesicles and their role in aging-related immunosenescence and immune response
  651. Nonpharmacologic therapeutic possibilities for immunosenescence
  652. Effects of mTOR Inhibition on immunosenescence in the Elderly
  653. Zinc-binding proteins (metallothionein and α-2 macroglobulin) as potential biological markers of immunosenescence
  654. Can Nutritional Intervention Counteract immunosenescence in the Elderly?
  655. Associations of Cytokine Polymorphisms with immunosenescence
  656. Involvement of immunosenescence in the frailty syndrome (85.13)
  657. Molecular Mechanisms of Compromised B-Cell Functions During immunosenescence.: Abstract# D2336
  658. Investigation of Molecular Mechanisms Involved in Retardation of immunosenescence in Caenorhabditis elegans by Royal Jelly
  659. THE IMPACT OF immunosenescence ON THE IMMUNE RESPONSES: A CHALLENGE ON INFLUENZA VACCINATION IN THE ELDERLY
  660. AB0050 immunosenescence of T and B cells in systemic sclerosis
  661. Human Cytomegalovirus as a driving force towards immunosenescence
  662. Insights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model
  663. Influenza virus vaccine adjuvant dominant in immunosenescence
  664. Pharmacological advantages of melatonin in immunosenescence by improving activity of T lymphocytes
  665. P1. 01-18 immunosenescence Correlates with Progression upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
  666. Transcription Factors and Checkpoint Inhibitor Expression with Age: Markers of immunosenescence?
  667. Abnormal regulation of T lymphocytes from aged rats contributes to immunosenescence
  668. Genes, Hormones, immunosenescence, and Environmental Agents: Toward an Integrated View of the Genesis of Autoimmune Disease
  669. Comparative Studies of Single Gene to Genes Groups on the Kidney Tonifying Method in Regulating immunosenescence
  670. Fat-rich diet-induced obese mice show premature immunosenescence
  671. Epigenetics and immunosenescence Reversal: An Evidence-Based Longevity Paradigm
  672. Erratum: Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
  673. Corrigendum: Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice
  674. P-glycoprotein expression in murine T lymphocytes: Implications for development, function, and immunosenescence.
  675. Metabolomic Profile of Human Serum to Determine the Age Related immunosenescence
  676. Corrigendum to ‘Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature’ …
  677. Insight into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model
  678. Effects of immunosenescence on professional antigen presenting cell immunogenicity in the context of Varicella zoster viral infection (APP3P. 114)
  679. immunosenescence: Telomere and telomerase dynamics in human T cells.
  680. The influence of immunosenescence on cancer immunotherapy: Cellular mechanisms of immunotherapy against the Lewis lung carcinoma with biological response …
  681. ROLE OF immunosenescence, FRAILTY, CMV AND VACCINE DOSE IN IMMUNE RESPONSES TO INFLUENZA VACCINATION
  682. The immunosenescence of Cytolytic T Lymphocytes (CTL): Reduction of Pore-Forming Protein and Granzyme Levels
  683. … life stress and perinatal glucocorticoid exposure produce complex immune system alterations, including accelerated T cell immunosenescence, in adolescent rhesus …
  684. Clinical Trials and Observations: Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II …
  685. Altered Naive and Memory T Cell Homeostasis and immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic …
  686. 406 Is immunosenescence infectious?
  687. Accelerated immunosenescence, the glial S100B protein and error-monitoring in remitted depression: A study to identify new candidates for state markers of …
  688. PS 17-15 THE RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA AND immunosenescence IN HYPERTENSIVE PATIENTS
  689. Omega-3 Polyunsaturated Fatty Acids and immunosenescence
  690. … lymphocytes in three age categories of luminal B-like breast cancer patients and its correlation with lymph node involvement and systemic immunosenescence/frailty …
  691. GROWTH DIFFERENTIATION FACTOR 15 IS CORRELATED TO MARKERS OF immunosenescence IN MONOCYTES
  692. 177. immunosenescence is associated with disease progression but not depression in presymptomatic stage B heart failure patients
  693. KS-1 immunosenescence in Critical Care
  694. 677 Older Patients with Hemodynamic Compromise Rejection: What Happened to immunosenescence?
  695. … into the binding of CLEC-2 platelets with podoplanin under flow and Comparing the cell intrinsic and environmental effects of immunosenescence on B cell response
  696. OS 01-08 IMPACT OF HYPERTENSION TREATMENT ON immunosenescence PARAMETERS
  697. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence

Related Posts

Shopping Cart
Scroll to Top